Department of Medical Informatics, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Department of Internal Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
Artif Intell Med. 2013 Sep;59(1):23-31. doi: 10.1016/j.artmed.2013.04.009. Epub 2013 Jun 2.
The rising incidence of type 2 diabetes mellitus (T2DM) induces severe challenges for the health care system. Our research group developed a web-based system named PANDIT that provides T2DM patients with insulin dosing advice using state of the art clinical decision support technology. The PANDIT interface resembles a glucose diary and provides advice through pop-up messages. Diabetes nurses (DNs) also have access to the system, allowing them to intervene when needed. The objective of this study was to establish whether T2DM patients can safely use PANDIT at home. To this end, we assessed whether patients experience usability problems with a high risk of compromising patient safety when interacting with the system, and whether PANDIT's insulin dosing advice are clinically safe.
The study population consisted of patients with T2DM (aged 18-80) who used a once daily basal insulin as well as DNs from a university hospital. The usability evaluation consisted of think-aloud sessions with four patients and three DNs. Video data, audio data and verbal utterances were analyzed for usability problems encountered during PANDIT interactions. Usability problems were rated by a physician and a usability expert according to their potential impact on patient safety. The usability evaluation was followed by an implementation with a duration of four weeks. This implementation took place at the patients' homes with ten patients to evaluate clinical safety of PANDIT advice. PANDIT advice were systematically compared with DN advice. Deviating advice were evaluated with respect to patient safety by a panel of experienced physicians, which specialized in diabetes care.
We detected seventeen unique usability problems, none of which was judged to have a high risk of compromising patient safety. Most usability problems concerned the lay-out of the diary, which did not clearly indicate which data entry fields had to be entered in order to obtain an advice. 27 out of 74 (36.5%) PANDIT advice differed from those provided by DNs. However, only one of these (1.4%) was considered unsafe by the panel.
T2DM patients with no prior experience with the web-based self-management system were capable of consulting the system without encountering significant usability problems. Furthermore, the large majority of PANDIT advice were considered clinically safe according to the expert panel. One advice was considered unsafe. This could however easily be corrected by implementing a small modification to the system's knowledge base.
2 型糖尿病(T2DM)发病率的上升给医疗保健系统带来了严峻挑战。我们的研究团队开发了一个名为 PANDIT 的基于网络的系统,该系统使用最先进的临床决策支持技术为 T2DM 患者提供胰岛素剂量建议。PANDIT 界面类似于血糖日记,并通过弹出消息提供建议。糖尿病护士(DN)也可以访问该系统,以便在需要时进行干预。本研究的目的是确定 T2DM 患者在家中使用 PANDIT 是否安全。为此,我们评估了患者在与系统交互时是否会遇到存在安全风险的可用性问题,以及 PANDIT 的胰岛素剂量建议是否具有临床安全性。
研究人群包括使用每日一次基础胰岛素的 T2DM 患者(年龄 18-80 岁)和来自一所大学医院的 DN。可用性评估包括对四名患者和三名 DN 进行的出声思考会议。分析 PANDIT 交互过程中遇到的可用性问题的视频数据、音频数据和口头陈述。根据对患者安全的潜在影响,由一名医生和一名可用性专家对可用性问题进行评分。可用性评估后,进行了为期四周的实施。该实施在患者家中进行,共有十名患者参与,以评估 PANDIT 建议的临床安全性。系统比较了 PANDIT 建议和 DN 建议。有经验的糖尿病护理专家组成的小组评估了有偏差的建议是否存在安全风险。
我们发现了十七个独特的可用性问题,没有一个被认为有高风险会危及患者安全。大多数可用性问题涉及到日记的布局,没有清楚地表明要获得建议,必须输入哪些数据输入字段。74 条 PANDIT 建议中有 27 条(36.5%)与 DN 提供的建议不同。然而,只有一条(1.4%)被专家组认为不安全。
没有使用过基于网络的自我管理系统的 T2DM 患者能够咨询该系统,而不会遇到重大的可用性问题。此外,根据专家组的意见,大多数 PANDIT 建议被认为具有临床安全性。有一条建议被认为不安全。但是,通过对系统知识库进行小的修改,可以很容易地纠正这一问题。